811 related articles for article (PubMed ID: 20080689)
21. Mammalian Hippo kinase pathway is downregulated by BCL-2 via protein degradation.
Won GW; Park SH; Park J; Lee Y; Lee YH
Biochem Biophys Res Commun; 2019 Apr; 512(1):87-92. PubMed ID: 30867124
[TBL] [Abstract][Full Text] [Related]
22. Tubule-Specific Mst1/2 Deficiency Induces CKD
Xu C; Wang L; Zhang Y; Li W; Li J; Wang Y; Meng C; Qin J; Zheng ZH; Lan HY; Mak KK; Huang Y; Xia Y
J Am Soc Nephrol; 2020 May; 31(5):946-961. PubMed ID: 32253273
[TBL] [Abstract][Full Text] [Related]
23. Non-canonical Hippo signaling regulates immune responses.
Chen L
Adv Immunol; 2019; 144():87-119. PubMed ID: 31699221
[TBL] [Abstract][Full Text] [Related]
24. DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2.
Kwan J; Sczaniecka A; Heidary Arash E; Nguyen L; Chen CC; Ratkovic S; Klezovitch O; Attisano L; McNeill H; Emili A; Vasioukhin V
Genes Dev; 2016 Dec; 30(24):2696-2709. PubMed ID: 28087714
[TBL] [Abstract][Full Text] [Related]
25. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation.
Kim W; Khan SK; Yang Y
BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216
[TBL] [Abstract][Full Text] [Related]
26. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
27. Hippo kinases Mst1 and Mst2 maintain NK cell homeostasis by orchestrating metabolic state and transcriptional activity.
Feng P; Luo L; Yang Q; Meng W; Guan Z; Li Z; Sun G; Dong Z; Yang M
Cell Death Dis; 2024 Jun; 15(6):430. PubMed ID: 38898027
[TBL] [Abstract][Full Text] [Related]
28. The functions of the Hippo signaling pathway in immune cells.
Yu SJ; Geng J; Chen LF
Yi Chuan; 2017 Jul; 39(7):650-658. PubMed ID: 28757479
[TBL] [Abstract][Full Text] [Related]
29. The Hippo/MST Pathway Member SAV1 Plays a Suppressive Role in Development of the Prehierarchical Follicles in Hen Ovary.
Lyu Z; Qin N; Tyasi TL; Zhu H; Liu D; Yuan S; Xu R
PLoS One; 2016; 11(8):e0160896. PubMed ID: 27505353
[TBL] [Abstract][Full Text] [Related]
30. Glycogen accumulation and phase separation drives liver tumor initiation.
Liu Q; Li J; Zhang W; Xiao C; Zhang S; Nian C; Li J; Su D; Chen L; Zhao Q; Shao H; Zhao H; Chen Q; Li Y; Geng J; Hong L; Lin S; Wu Q; Deng X; Ke R; Ding J; Johnson RL; Liu X; Chen L; Zhou D
Cell; 2021 Oct; 184(22):5559-5576.e19. PubMed ID: 34678143
[TBL] [Abstract][Full Text] [Related]
31. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
32. Two Hippo signaling modules orchestrate liver size and tumorigenesis.
Qi S; Zhong Z; Zhu Y; Wang Y; Ma M; Wang Y; Liu X; Jin R; Jiao Z; Zhu R; Sha Z; Dang K; Liu Y; Lim DS; Mao J; Zhang L; Yu FX
EMBO J; 2023 Jun; 42(11):e112126. PubMed ID: 36919851
[TBL] [Abstract][Full Text] [Related]
33. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.
Wu H; Wei L; Fan F; Ji S; Zhang S; Geng J; Hong L; Fan X; Chen Q; Tian J; Jiang M; Sun X; Jin C; Yin ZY; Liu Q; Zhang J; Qin F; Lin KH; Yu JS; Deng X; Wang HR; Zhao B; Johnson RL; Chen L; Zhou D
Nat Commun; 2015 Feb; 6():6239. PubMed ID: 25695629
[TBL] [Abstract][Full Text] [Related]
34. Increasing kinase domain proximity promotes MST2 autophosphorylation during Hippo signaling.
Tran T; Mitra J; Ha T; Kavran JM
J Biol Chem; 2020 Nov; 295(47):16166-16179. PubMed ID: 32994222
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
36. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.
Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N
Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874
[TBL] [Abstract][Full Text] [Related]
37. SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.
Bae SJ; Ni L; Osinski A; Tomchick DR; Brautigam CA; Luo X
Elife; 2017 Oct; 6():. PubMed ID: 29063833
[TBL] [Abstract][Full Text] [Related]
38. Expression of hippo pathway in colorectal cancer.
Liang K; Zhou G; Zhang Q; Li J; Zhang C
Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
[TBL] [Abstract][Full Text] [Related]
39. KIBRA connects Hippo signaling and cancer.
Swaroop B SS; Kanumuri R; Ezhil I; Naidu Sampangi JK; Kremerskothen J; Rayala SK; Venkatraman G
Exp Cell Res; 2021 Jun; 403(2):112613. PubMed ID: 33901448
[TBL] [Abstract][Full Text] [Related]
40. Liraglutide suppresses proliferation and induces adipogenic differentiation of 3T3-L1 cells via the Hippo-YAP signaling pathway.
Li Y; Du J; Zhu E; Zhang J; Han J; Zhao W; Sun B; Tian D
Mol Med Rep; 2018 Mar; 17(3):4499-4507. PubMed ID: 29344656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
